ArticleMolecular therapy. Oncology2024

Targeting the membrane-proximal C2-set domain of CD33 for improved CAR T cell therapy.

Salvatore Fiorenza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.